Lapatinib Completed Phase 1 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02073916T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer